Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study

Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Elena I. Danilova [verfasserIn] Oksana Yu. Trusova [verfasserIn] Anton N. Roschupkin [verfasserIn] Zinaida A. Veterkova [verfasserIn] Ekaterina I. Golovacheva [verfasserIn] Tatiana N. Ignatova [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Russisch

Erschienen:	2016

Schlagwörter:	дети атопический дерматит энтеросорбенты

Übergeordnetes Werk:	In: Вопросы современной педиатрии - "Paediatrician" Publishers LLC, 2017, 15(2016), 3, Seite 268-272
Übergeordnetes Werk:	volume:15 ; year:2016 ; number:3 ; pages:268-272

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.15690/vsp.v15i3.1564

Katalog-ID:	DOAJ029191297

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ029191297
003	DE-627
005	20230410114751.0
007	cr uuu---uuuuu
008	230226s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.15690/vsp.v15i3.1564 \|2 doi
035			\|a (DE-627)DOAJ029191297
035			\|a (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a rus
050		0	\|a RJ1-570
100	0		\|a Elena I. Danilova \|e verfasserin \|4 aut
245	1	0	\|a Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process.
650		4	\|a дети
650		4	\|a атопический дерматит
650		4	\|a энтеросорбенты
653		0	\|a Pediatrics
700	0		\|a Oksana Yu. Trusova \|e verfasserin \|4 aut
700	0		\|a Anton N. Roschupkin \|e verfasserin \|4 aut
700	0		\|a Zinaida A. Veterkova \|e verfasserin \|4 aut
700	0		\|a Ekaterina I. Golovacheva \|e verfasserin \|4 aut
700	0		\|a Tatiana N. Ignatova \|e verfasserin \|4 aut
773	0	8	\|i In \|t Вопросы современной педиатрии \|d "Paediatrician" Publishers LLC, 2017 \|g 15(2016), 3, Seite 268-272 \|w (DE-627)1760615773 \|x 16825535 \|7 nnns
773	1	8	\|g volume:15 \|g year:2016 \|g number:3 \|g pages:268-272
856	4	0	\|u https://doi.org/10.15690/vsp.v15i3.1564 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 \|z kostenfrei
856	4	0	\|u https://vsp.spr-journal.ru/jour/article/view/1639 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1682-5527 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1682-5535 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
951			\|a AR
952			\|d 15 \|j 2016 \|e 3 \|h 268-272

Indexfelder

author_variant	e i d eid o y t oyt a n r anr z a v zav e i g eig t n i tni
matchkey_str	article:16825535:2016----::fiayfneoobnbsdnetnnlnnfneetatnraighlrnihtpcem
hierarchy_sort_str	2016
callnumber-subject-code	RJ
publishDate	2016
allfields	10.15690/vsp.v15i3.1564 doi (DE-627)DOAJ029191297 (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56 DE-627 ger DE-627 rakwb eng rus RJ1-570 Elena I. Danilova verfasserin aut Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process. дети атопический дерматит энтеросорбенты Pediatrics Oksana Yu. Trusova verfasserin aut Anton N. Roschupkin verfasserin aut Zinaida A. Veterkova verfasserin aut Ekaterina I. Golovacheva verfasserin aut Tatiana N. Ignatova verfasserin aut In Вопросы современной педиатрии "Paediatrician" Publishers LLC, 2017 15(2016), 3, Seite 268-272 (DE-627)1760615773 16825535 nnns volume:15 year:2016 number:3 pages:268-272 https://doi.org/10.15690/vsp.v15i3.1564 kostenfrei https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 kostenfrei https://vsp.spr-journal.ru/jour/article/view/1639 kostenfrei https://doaj.org/toc/1682-5527 Journal toc kostenfrei https://doaj.org/toc/1682-5535 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 15 2016 3 268-272
spelling	10.15690/vsp.v15i3.1564 doi (DE-627)DOAJ029191297 (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56 DE-627 ger DE-627 rakwb eng rus RJ1-570 Elena I. Danilova verfasserin aut Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process. дети атопический дерматит энтеросорбенты Pediatrics Oksana Yu. Trusova verfasserin aut Anton N. Roschupkin verfasserin aut Zinaida A. Veterkova verfasserin aut Ekaterina I. Golovacheva verfasserin aut Tatiana N. Ignatova verfasserin aut In Вопросы современной педиатрии "Paediatrician" Publishers LLC, 2017 15(2016), 3, Seite 268-272 (DE-627)1760615773 16825535 nnns volume:15 year:2016 number:3 pages:268-272 https://doi.org/10.15690/vsp.v15i3.1564 kostenfrei https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 kostenfrei https://vsp.spr-journal.ru/jour/article/view/1639 kostenfrei https://doaj.org/toc/1682-5527 Journal toc kostenfrei https://doaj.org/toc/1682-5535 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 15 2016 3 268-272
allfields_unstemmed	10.15690/vsp.v15i3.1564 doi (DE-627)DOAJ029191297 (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56 DE-627 ger DE-627 rakwb eng rus RJ1-570 Elena I. Danilova verfasserin aut Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process. дети атопический дерматит энтеросорбенты Pediatrics Oksana Yu. Trusova verfasserin aut Anton N. Roschupkin verfasserin aut Zinaida A. Veterkova verfasserin aut Ekaterina I. Golovacheva verfasserin aut Tatiana N. Ignatova verfasserin aut In Вопросы современной педиатрии "Paediatrician" Publishers LLC, 2017 15(2016), 3, Seite 268-272 (DE-627)1760615773 16825535 nnns volume:15 year:2016 number:3 pages:268-272 https://doi.org/10.15690/vsp.v15i3.1564 kostenfrei https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 kostenfrei https://vsp.spr-journal.ru/jour/article/view/1639 kostenfrei https://doaj.org/toc/1682-5527 Journal toc kostenfrei https://doaj.org/toc/1682-5535 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 15 2016 3 268-272
allfieldsGer	10.15690/vsp.v15i3.1564 doi (DE-627)DOAJ029191297 (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56 DE-627 ger DE-627 rakwb eng rus RJ1-570 Elena I. Danilova verfasserin aut Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process. дети атопический дерматит энтеросорбенты Pediatrics Oksana Yu. Trusova verfasserin aut Anton N. Roschupkin verfasserin aut Zinaida A. Veterkova verfasserin aut Ekaterina I. Golovacheva verfasserin aut Tatiana N. Ignatova verfasserin aut In Вопросы современной педиатрии "Paediatrician" Publishers LLC, 2017 15(2016), 3, Seite 268-272 (DE-627)1760615773 16825535 nnns volume:15 year:2016 number:3 pages:268-272 https://doi.org/10.15690/vsp.v15i3.1564 kostenfrei https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 kostenfrei https://vsp.spr-journal.ru/jour/article/view/1639 kostenfrei https://doaj.org/toc/1682-5527 Journal toc kostenfrei https://doaj.org/toc/1682-5535 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 15 2016 3 268-272
allfieldsSound	10.15690/vsp.v15i3.1564 doi (DE-627)DOAJ029191297 (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56 DE-627 ger DE-627 rakwb eng rus RJ1-570 Elena I. Danilova verfasserin aut Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process. дети атопический дерматит энтеросорбенты Pediatrics Oksana Yu. Trusova verfasserin aut Anton N. Roschupkin verfasserin aut Zinaida A. Veterkova verfasserin aut Ekaterina I. Golovacheva verfasserin aut Tatiana N. Ignatova verfasserin aut In Вопросы современной педиатрии "Paediatrician" Publishers LLC, 2017 15(2016), 3, Seite 268-272 (DE-627)1760615773 16825535 nnns volume:15 year:2016 number:3 pages:268-272 https://doi.org/10.15690/vsp.v15i3.1564 kostenfrei https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 kostenfrei https://vsp.spr-journal.ru/jour/article/view/1639 kostenfrei https://doaj.org/toc/1682-5527 Journal toc kostenfrei https://doaj.org/toc/1682-5535 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 15 2016 3 268-272
language	English Russian
source	In Вопросы современной педиатрии 15(2016), 3, Seite 268-272 volume:15 year:2016 number:3 pages:268-272
sourceStr	In Вопросы современной педиатрии 15(2016), 3, Seite 268-272 volume:15 year:2016 number:3 pages:268-272
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	дети атопический дерматит энтеросорбенты Pediatrics
isfreeaccess_bool	true
container_title	Вопросы современной педиатрии
authorswithroles_txt_mv	Elena I. Danilova @@aut@@ Oksana Yu. Trusova @@aut@@ Anton N. Roschupkin @@aut@@ Zinaida A. Veterkova @@aut@@ Ekaterina I. Golovacheva @@aut@@ Tatiana N. Ignatova @@aut@@
publishDateDaySort_date	2016-01-01T00:00:00Z
hierarchy_top_id	1760615773
id	DOAJ029191297
language_de	englisch russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ029191297</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410114751.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.15690/vsp.v15i3.1564</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ029191297</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RJ1-570</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Elena I. Danilova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p &lt; 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p &lt; 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р &lt; 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">дети</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">атопический дерматит</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">энтеросорбенты</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pediatrics</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Oksana Yu. Trusova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anton N. Roschupkin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zinaida A. Veterkova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ekaterina I. Golovacheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tatiana N. Ignatova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Вопросы современной педиатрии</subfield><subfield code="d">"Paediatrician" Publishers LLC, 2017</subfield><subfield code="g">15(2016), 3, Seite 268-272</subfield><subfield code="w">(DE-627)1760615773</subfield><subfield code="x">16825535</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:268-272</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.15690/vsp.v15i3.1564</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://vsp.spr-journal.ru/jour/article/view/1639</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1682-5527</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1682-5535</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2016</subfield><subfield code="e">3</subfield><subfield code="h">268-272</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Elena I. Danilova
spellingShingle	Elena I. Danilova misc RJ1-570 misc дети misc атопический дерматит misc энтеросорбенты misc Pediatrics Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study
authorStr	Elena I. Danilova
ppnlink_with_tag_str_mv	@@773@@(DE-627)1760615773
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RJ1-570
illustrated	Not Illustrated
issn	16825535
topic_title	RJ1-570 Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study дети атопический дерматит энтеросорбенты
topic	misc RJ1-570 misc дети misc атопический дерматит misc энтеросорбенты misc Pediatrics
topic_unstemmed	misc RJ1-570 misc дети misc атопический дерматит misc энтеросорбенты misc Pediatrics
topic_browse	misc RJ1-570 misc дети misc атопический дерматит misc энтеросорбенты misc Pediatrics
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Вопросы современной педиатрии
hierarchy_parent_id	1760615773
hierarchy_top_title	Вопросы современной педиатрии
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1760615773
title	Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study
ctrlnum	(DE-627)DOAJ029191297 (DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56
title_full	Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study
author_sort	Elena I. Danilova
journal	Вопросы современной педиатрии
journalStr	Вопросы современной педиатрии
callnumber-first-code	R
lang_code	eng rus
isOA_bool	true
recordtype	marc
publishDateSort	2016
contenttype_str_mv	txt
container_start_page	268
author_browse	Elena I. Danilova Oksana Yu. Trusova Anton N. Roschupkin Zinaida A. Veterkova Ekaterina I. Golovacheva Tatiana N. Ignatova
container_volume	15
class	RJ1-570
format_se	Elektronische Aufsätze
author-letter	Elena I. Danilova
doi_str_mv	10.15690/vsp.v15i3.1564
author2-role	verfasserin
title_sort	efficacy of enterosorbent based on pectin, inulin and fennel extract in treating children with atopic dermatitis: «case-control» prospective study
callnumber	RJ1-570
title_auth	Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study
abstract	Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process.
abstractGer	Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process.
abstract_unstemmed	Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p < 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p < 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р < 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ
container_issue	3
title_short	Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study
url	https://doi.org/10.15690/vsp.v15i3.1564 https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56 https://vsp.spr-journal.ru/jour/article/view/1639 https://doaj.org/toc/1682-5527 https://doaj.org/toc/1682-5535
remote_bool	true
author2	Oksana Yu. Trusova Anton N. Roschupkin Zinaida A. Veterkova Ekaterina I. Golovacheva Tatiana N. Ignatova
author2Str	Oksana Yu. Trusova Anton N. Roschupkin Zinaida A. Veterkova Ekaterina I. Golovacheva Tatiana N. Ignatova
ppnlink	1760615773
callnumber-subject	RJ - Pediatrics
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.15690/vsp.v15i3.1564
callnumber-a	RJ1-570
up_date	2024-07-03T21:39:16.066Z
_version_	1803595552986759168
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ029191297</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230410114751.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.15690/vsp.v15i3.1564</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ029191297</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJe94a991a445641ae9a75afbcfe3a0c56</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RJ1-570</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Elena I. Danilova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Atopic dermatitis (AD) is an important issue, significance of which is determined by the incidence increase, chronic, relapsing course of the disease, and poor treatment efficacy.Objective: Our aim was to study clinical efficacy of enterosorbent based on pectin, inulin and fennel extract in combined AD treatment in children.Methods: «Case-control» prospective study included children from 3 to 11 years admitted to hospital with moderate AD.Results: 20 patients included in the study took enterosorbent in addition to the basic therapy, 20 patients had only basic therapy. Compared groups were matched by sex, age, and AD severity by SCORAD scale. Cutaneous AD manifestations in the main group were arrested average over the period of 3.4 ± 1.2 days, in the control group — of 4.7 ± 1.5 days (p &lt; 0.001), skin itch — of 4.0 ± 0.9 and 6.8 ± 1.4 days (p &lt; 0.001), skin dryness — of 9.8 ± 1.1 and 12.3 ± 1.6 days, respectively (р &lt; 0.001).Conclusion: Adding enterosorbent containing pectin, inulin and fennel extract to the basic therapy of moderate AD makes it easier to arrest the clinical manifestations of an acute allergic process.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">дети</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">атопический дерматит</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">энтеросорбенты</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pediatrics</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Oksana Yu. Trusova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anton N. Roschupkin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Zinaida A. Veterkova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ekaterina I. Golovacheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tatiana N. Ignatova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Вопросы современной педиатрии</subfield><subfield code="d">"Paediatrician" Publishers LLC, 2017</subfield><subfield code="g">15(2016), 3, Seite 268-272</subfield><subfield code="w">(DE-627)1760615773</subfield><subfield code="x">16825535</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:15</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:268-272</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.15690/vsp.v15i3.1564</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/e94a991a445641ae9a75afbcfe3a0c56</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://vsp.spr-journal.ru/jour/article/view/1639</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1682-5527</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1682-5535</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">15</subfield><subfield code="j">2016</subfield><subfield code="e">3</subfield><subfield code="h">268-272</subfield></datafield></record></collection>
score	7.4006615

Nicht das Richtige dabei?

Schreiben Sie uns!

Efficacy of Enterosorbent Based on Pectin, Inulin and Fennel Extract in Treating Children with Atopic Dermatitis: «Case-Control» Prospective Study

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?